Bioconjugation chemistry has made tremendous improvements over the last few decades; it has found applications virtually everywhere in the life sciences industry. We now can create exciting and useful molecules at will by revamping existing biomolecules, but this excitement happens mostly at the chemical research level. A disconnect exists between the people who can create the molecules and the people who can actually use the molecules. Part of the reason is a lack of robust chemistry and general procedures for everyone to follow, the complexities of the biomolecules involved, and the difficulties in analyzing and purifying bioconjugates.

At CellMosaic, it is our mission to make the bioconjugate a science commodity by providing our reagents/ready-to-go kits or custom bioconjugation services.

In the drug development field, it is our mission to apply our proprietary AqueaTether™ technologies to the existing drug molecules to create new, pharmacokinetically and pharmacodynamically superior drug entities, enabling maximum returns for pharmaceutical companies.